McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P. Initial experience with FK506 in pediatric renal transplant patients. J Pediatr Surg. 1997 May;32(5):688.

Takiyama Y, Saji M, Clark DP, Phillips GS, Segev DL, Smallridge RC, Westra WH, Udelsman R, Zeiger MA. PCR-based microsatellite analysis of fine needle aspirations (FNA) from Hurthle cell neoplasms. Thyroid. 1997 Dec;7(6):853.

Lipsett P, Segev DL, Colombani P. Biliary atresia and biliary cysts. Baillieres Clin Gastroenterol. 1997 Dec;11(4):619.

Ringel MD, Saji M, Schwindinger WF, Segev D, Zeiger MA, Levine MA. Absence of activating mutations of the genes enconding the alpha-subunits of G11 and Gq in thyroid neoplasia. J Clin Endocrinol Metab. 1998 Feb;83(2):554.

Segev DL, Saji M, Phillips GS, Westra WH, Takiyama Y, Piantadosi S, Smallridge RC, Nishiyama RH, Udelsman R, Zeiger MA. PCR-based microsatellite polymorphism analysis of follicular and Hurthle cell neoplasms of the thyroid. J Clin Endocrinol Metab. 1998 Jun;83(6):2036.

Segev DL, Ha TU, Tran TT, Kenneally M, Harkin P, Jung M, MacLaughlin DT, Donahoe PK, Maheswaran S. Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway. J Biol Chem. 2000 Sep 15;275(37):28371.

Ha TU, Segev DL, Barbie D, Masiakos PT, Tran TT, Dombkowski D, Glander M, Clarke TR, Lorenzo HK, Donahoe PK, Maheswaran S. Mullerian Inhibiting Substance inhibits ovarian epithelial cell growth through an Rb independent mechanism. J Biol Chem. 2000 Nov 24;275(47):37101.

Stephen AE, Masiakos PT, Segev DL, Vacanti JP, Donahoe PK, MacLaughlin DT. Tissue Engineered Cells Producing Complex Recombinant Proteins Inhibit Ovarian Cancer In Vivo. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3214.

Segev DL, Hoshiya Y, Stephen AE, Hoshiya M, Tran TT, MacLaughlin DT, Donahoe PK, Maheswaran S. Mullerian Inhibiting Substance Regulates NFkB Signaling and Growth of Mammary Epithelial Cells in vivo. J Biol Chem 2001 Jul 20;276(29):26799.

Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey J, Stephen AE, MacLaughlin DT, Donahoe PK, Maheswaran S. Mullerian Inhibiting Substance Regulates NFkB Signaling in the Prostate in vitro and in vivo. Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):239.

Stephen AE, Segev DL, Ryan DP, Mullins ME, Kim SH, Schnitzer JJ, Doody DP. The Diagnosis of Acute Appendicitis in a Pediatric Population: To CT or not to CT. J Pediatr Surg. 2003 Mar;38(3):367.

Hoshiya Y, Gupta V, Segev DL, Hoshiya M, Carey JL, Sasur LM, Tran TT, Ha TU, Maheswaran S. Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells. Mol Cell Endocrinol 2003 Dec;211(1):43.

Segev DL, Umbricht C, Zeiger MA. Molecular pathogenesis of thyroid cancer. Surg Oncol 2003 Aug;12(2):69.

Segev DL, Clark DP, Zeiger MA, Umbricht C. Beyond the suspicious thyroid fine needle aspirate. Acta Cytol 2003 Sep-Oct;47(5):709.

Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA. Kidney Paired Donation and optimizing the use of live donor organs. JAMA. 2005 Apr 20;293(15):1883-90.

Segev DL, Molmenti EP, Arepally A, Hong J, Rai R, Thuluvath PJ, Klein AS. The Utility of TIPS in the management of Budd-Chiari Syndrome. (Segev DL and Molmenti EP are co-first authors) Ann Surg. 2005 Jun;241(6):978-983.

Gentry SE, Segev DL, Montgomery RA. A comparison of populations served by Kidney Paired Donation and List Paired Donation. Am J Transplant. 2005 Aug;5(8):1914-21.

Segev DL, Simpkins CE, Warren DS, King KE, Maley WR, Melancon JK, Cooper M, Kozlowski T, Montgomery RA. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant. 2005. Oct;5(10):2570-75.

Segev DL, Gentry SE, Melancon JK, Montgomery RA. Characterization of waiting times in a simulation of kidney paired donation. Am J Transplant. 2005. Oct;5(10):2448-55.

Montgomery RA, Zachary AA, Ratner LE, Segev DL, Hiller JM, Houp J, Cooper M, Kavoussi L, Jarrett T, Burdick J, Maley WR, Melancon JK, Kozlowski T, Simpkins CE, Phillips M, Desai A, Collins V, Reeb B, Kraus E, Rabb H, Leffell MS, Warren DS. Kidney Paired Donation permits successful transplantation with incompatible live kidney donors. JAMA. 2005 Oct 5;294(13):1655-63.

Segev DL, Gentry SE, Melancon JK, Maley WR, Warren DS, Simpkins CE, Locke JE, Montgomery RA. Kidney Paired Donation: A Solution for transplanting patients with incompatible live kidney donors. Surgery. In press.

Stewart ZA, Kozlowski T, Segev DL, Montgomery RA, Klein AS. Successful transplantation of a polycystic liver: case report and review of the literature. Transplantation. In press.

Segev DL, Gentry SE, Montgomery RA. Relative roles for list Paired exchange, live donor paired exchange, and desensitization. Am J Transplant. In press.

Books

Surgical Dictation Pocket Survival Guide (Segev, ed) International Medical Publishing. 2004.

Incompatible Solid Organ Transplantation (Segev and Montgomery, eds) Springer. Anticipated publication summer 2006.